Lista de obras - Amany Zekry - Dominio Público Uruguay

A Tale of Two Fibers: A Liver Twist!

A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134.

artículo científico publicado en 2011

A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection.

artículo científico publicado en 2008

A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection

artículo científico publicado en 2004

Adherence to Hepatitis B Antiviral Therapy: A Qualitative Study

artículo científico publicado en 2017

Barriers faced by migrants in accessing healthcare for viral hepatitis infection ⬇️

artículo científico publicado el 1 de mayo de 2012

Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels

artículo científico publicado en 2019

Characterisation of the cytokine milieu associated with the up-regulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders

artículo científico publicado en 2014

Chemokine-regulated recruitment of antigen-specific T cell sub-populations to the liver in acute and chronic hepatitis C infection

artículo científico publicado en 2018

Chronic hepatitis B infection in an Australian antenatal population: seroprevalence and opportunities for better outcomes.

artículo científico publicado en 2009

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

artículo científico publicado en 2009

Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study

artículo científico publicado en 2014

Community screening identifies undiagnosed chronic liver disease in high‐risk populations

Cytokines and liver injury in chronic HCV genotype 4 infection.

artículo científico publicado en 2009

Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.

artículo científico publicado en 2017

Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with HCV genotype 2, 4, 5, or 6 infection: the C-SCAPE study

artículo científico publicado en 2017

Eltrombopag: Is this "24 karat gold platelet" treatment for thrombocytopenia in cirrhosis associated with hepatitis C?

artículo científico publicado en 2008

Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia

artículo científico publicado en 2014

Factors associated with HBV virological breakthrough.

artículo científico publicado en 2016

Factors associated with medication adherence in patients living with cirrhosis.

artículo científico publicado en 2016

Factors associated with non-adherence to HBV antiviral therapy.

artículo científico publicado en 2017

Factors influencing the participation of gastroenterologists and hepatologists in clinical research

artículo científico publicado en 2008

Gastroenterology hospital outpatients report high rates of satisfaction with a Telehealth model of care

General practitioners require more support to prescribe direct acting antiviral therapy for hepatitis C.

artículo científico publicado en 2018

General practitioners' knowledge and management of viral hepatitis in the migrant population ⬇️

artículo científico publicado el 1 de mayo de 2012

Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma

HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths.

artículo científico publicado en 2015

Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up

Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection.

artículo científico publicado en 2016

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

artículo científico publicado en 2014

Impact of immunosuppression on immunopathogenesis of liver damage in hepatitis C virus-infected recipients following liver transplantation ⬇️

artículo científico publicado el 1 de noviembre de 2003

Insulin resistance and steatosis in hepatitis C virus infection.

artículo científico publicado en 2005

Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase.

artículo científico publicado en 2008

Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.

artículo científico

Is re-treatment with peginterferon alpha-2a and ribavirin effective in patients with relapsed chronic hepatitis C?

artículo científico publicado en 2007

Is the current standard therapy for hepatitis C of peginterferon and ribavirin an option for patients coinfected with HIV?

artículo científico publicado en 2004

Knowledge of Treatment and Disease Questionnaire

Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort

Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity

artículo científico publicado en 2015

MEDICAL COMPLICATIONS OF HOMELESSNESS: A NEGLECTED SIDE OF MEN'S HEALTH

article

Mechanisms of HCV reinfection and allograft damage after liver transplantation

artículo científico publicado en 2004

Modulation of the Gut Microbiome to Improve Clinical Outcomes in Hepatocellular Carcinoma

Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus

scholarly article

New Drugs for the Management of Hepatitis C

Non-alcoholic fatty liver disease (NAFLD): a review of epidemiology, risk factors, diagnosis and management

scientific article published on 24 November 2019

Palliation of hilar biliary obstruction from colorectal metastases by endoscopic stent insertion.

artículo científico publicado en 2000

Pathogenesis of hepatitis C virus recurrence in the liver allograft

artículo científico publicado en 2002

Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression

artículo científico publicado en 2014

Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL study.

artículo científico publicado en 2017

Refining a Protocol for Faecal Microbiota Engraftment in Animal Models After Successful Antibiotic-Induced Gut Decontamination

artículo científico publicado en 2022

Regulation of T cell recruitment and inflammation in the human immunodeficiency virus/hepatitis C virus coinfected liver

artículo científico publicado en 2014

Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse.

artículo científico publicado en 2017

Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for Hepatitis C.

scientific article published on March 2008

Selective internal radiation therapy for hepatocellular carcinoma: A 15‐year multicenter Australian cohort study

Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection

artículo científico publicado en 2007

Standard Therapy for Genotypes 2/3

Steatosis and chronic hepatitis C virus infection: mechanisms and significance.

artículo científico publicado en 2005

Strategies to manage hepatitis C virus (HCV) disease burden.

artículo científico publicado en 2014

The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection.

artículo científico publicado en 2009

The long and the short of interferon-gamma–inducible protein 10 in hepatitis C virus infection ⬇️

artículo científico publicado el 1 de noviembre de 2011

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

artículo científico publicado en 2014

Tinkering and tailoring with HCV therapy: can we get away with less?

artículo científico publicado en 2004

Treatment of acute hepatitis C infection: more pieces of the puzzle?

artículo científico publicado en 2005

Treatment responses in Asians and Caucasians with chronic hepatitis C infection

artículo científico publicado en 2008

Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapy.

artículo científico publicado en 2018

Lista de obras de Amany Zekry

A Tale of Two Fibers: A Liver Twist!

A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134.

A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection.

A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection

Adherence to Hepatitis B Antiviral Therapy: A Qualitative Study

Barriers faced by migrants in accessing healthcare for viral hepatitis infection ⬇️

Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels

Characterisation of the cytokine milieu associated with the up-regulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders

Chemokine-regulated recruitment of antigen-specific T cell sub-populations to the liver in acute and chronic hepatitis C infection

Chronic hepatitis B infection in an Australian antenatal population: seroprevalence and opportunities for better outcomes.

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study

Community screening identifies undiagnosed chronic liver disease in high‐risk populations

Cytokines and liver injury in chronic HCV genotype 4 infection.

Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.

Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with HCV genotype 2, 4, 5, or 6 infection: the C-SCAPE study

Eltrombopag: Is this "24 karat gold platelet" treatment for thrombocytopenia in cirrhosis associated with hepatitis C?

Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia

Factors associated with HBV virological breakthrough.

Factors associated with medication adherence in patients living with cirrhosis.

Factors associated with non-adherence to HBV antiviral therapy.

Factors influencing the participation of gastroenterologists and hepatologists in clinical research

Gastroenterology hospital outpatients report high rates of satisfaction with a Telehealth model of care

General practitioners require more support to prescribe direct acting antiviral therapy for hepatitis C.

General practitioners' knowledge and management of viral hepatitis in the migrant population ⬇️

Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma

HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths.

Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up

Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection.

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

Impact of immunosuppression on immunopathogenesis of liver damage in hepatitis C virus-infected recipients following liver transplantation ⬇️

Insulin resistance and steatosis in hepatitis C virus infection.

Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase.

Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.

Is re-treatment with peginterferon alpha-2a and ribavirin effective in patients with relapsed chronic hepatitis C?

Is the current standard therapy for hepatitis C of peginterferon and ribavirin an option for patients coinfected with HIV?

Knowledge of Treatment and Disease Questionnaire

Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort

Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity

MEDICAL COMPLICATIONS OF HOMELESSNESS: A NEGLECTED SIDE OF MEN'S HEALTH

Mechanisms of HCV reinfection and allograft damage after liver transplantation

Modulation of the Gut Microbiome to Improve Clinical Outcomes in Hepatocellular Carcinoma

Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus

New Drugs for the Management of Hepatitis C

Non-alcoholic fatty liver disease (NAFLD): a review of epidemiology, risk factors, diagnosis and management

Palliation of hilar biliary obstruction from colorectal metastases by endoscopic stent insertion.

Pathogenesis of hepatitis C virus recurrence in the liver allograft

Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression

Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL study.

Refining a Protocol for Faecal Microbiota Engraftment in Animal Models After Successful Antibiotic-Induced Gut Decontamination

Regulation of T cell recruitment and inflammation in the human immunodeficiency virus/hepatitis C virus coinfected liver

Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse.

Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for Hepatitis C.

Selective internal radiation therapy for hepatocellular carcinoma: A 15‐year multicenter Australian cohort study

Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection

Standard Therapy for Genotypes 2/3

Steatosis and chronic hepatitis C virus infection: mechanisms and significance.

Strategies to manage hepatitis C virus (HCV) disease burden.

The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection.

The long and the short of interferon-gamma–inducible protein 10 in hepatitis C virus infection ⬇️

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Tinkering and tailoring with HCV therapy: can we get away with less?

Treatment of acute hepatitis C infection: more pieces of the puzzle?

Treatment responses in Asians and Caucasians with chronic hepatitis C infection

Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapy.

Virtual clinic for positive faecal occult blood tests enhances early access to bowel cancer screening and is well received by patients